Related Experiment Video
Updated: Jul 11, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Morphine-6-glucuronide (M6G) for postoperative pain relief
Albert Dahan1, Eveline van Dorp, Terry Smith
1Department of Anesthesiology, Leiden University Medical Center, P5-Q, P.O. Box 9600, 2300 RC Leiden, The Netherlands. a.dahan@lumc.nl
Abstract:
Morphine-6-glucuronide (M6G) is morphine's active metabolite acting at the mu-opioid receptor. Recent experimental human studies and 5 of 6 randomized clinical trials indicate that M6G causes adequate and long lasting pain relief comparable to morphine. There are various observations that M6G is associated with a reduction in the severity of side effects normally associated with opioid use, such as reduced postoperative nausea and vomiting (PONV) and reduced respiratory depression. The present drug profile provides a review of the pharmacological properties of M6G, the clinical evidence relating to its efficacy and safety, and discusses its future role in the treatment of postoperative pain.
Insights
Morphine-6-glucuronide (M6G) offers effective pain relief comparable to morphine. Studies suggest M6G may reduce opioid side effects like nausea and respiratory depression, indicating potential for improved postoperative pain management.
Area of Science:
- Pharmacology
- Pain Management
- Clinical Trials
Background:
- Morphine-6-glucuronide (M6G) is an active metabolite of morphine.
- M6G acts on the mu-opioid receptor.
- Opioid analgesics are commonly used for postoperative pain but are associated with side effects.
Purpose of the Study:
- To review the pharmacological properties of M6G.
- To evaluate the clinical evidence for M6G's efficacy and safety in pain relief.
- To discuss the potential future role of M6G in managing postoperative pain.
Main Methods:
- Review of experimental human studies.
- Analysis of randomized clinical trials.
- Pharmacological and clinical data assessment.
Main Results:
- M6G provides pain relief comparable to morphine.
- Evidence suggests M6G may reduce postoperative nausea and vomiting (PONV).
- M6G appears to cause less respiratory depression than morphine.
Conclusions:
- M6G demonstrates significant efficacy and a potentially favorable safety profile for postoperative pain.
- M6G may offer an alternative opioid analgesic with reduced side effect burden.
- Further research and clinical application of M6G in postoperative pain management are warranted.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Opioid Receptors: Overview
Parenteral Anesthetics: Overview
Peripheral Artery Disease V: Postoperative Nursing Management